These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9123213)

  • 1. Inhibition of IFN-gamma production by intravenous immunoglobulins during mixed lymphocyte reaction: consequences for proliferation and TNF-gamma production.
    Toungouz M; Denys C; Dupont E
    Transplant Proc; 1997; 29(1-2):1089. PubMed ID: 9123213
    [No Abstract]   [Full Text] [Related]  

  • 2. Blockade of proliferation and tumor necrosis factor-alpha production occurring during mixed lymphocyte reaction by interferon-gamma-specific natural antibodies contained in intravenous immunoglobulins.
    Toungouz M; Denys C; Dupont E
    Transplantation; 1996 Nov; 62(9):1292-6. PubMed ID: 8932274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased in vitro immunosuppressive action of anti-CMV and anti-HBs intravenous immunoglobulins due to higher amounts of interferon-gamma specific neutralizing antibodies.
    Denys C; Toungouz M; Dupont E
    Vox Sang; 1997; 72(4):247-50. PubMed ID: 9228717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of PD-L1 on monocytes: a new mechanism by which IVIg inhibits mixed lymphocyte reactions.
    Padet L; Loubaki L; Bazin R
    Immunobiology; 2014 Sep; 219(9):687-94. PubMed ID: 24875729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF enhances CD4+ T cell alloproliferation, IFN-gamma responses, and intestinal graft-versus-host disease by IL-12-independent mechanisms.
    Brown GR; Lee EL; Thiele DL
    J Immunol; 2003 May; 170(10):5082-8. PubMed ID: 12734353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal control of interferon-gamma and tumor necrosis factor-alpha by interleukin-10 produced in response to one HLA-DR mismatch during the primary mixed lymphocyte reaction.
    Toungouz M; Denys C; de Groote D; Andrien M; Dupont E
    Transplantation; 1996 Feb; 61(3):497-502. PubMed ID: 8610367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of IVIg to identify potential miRNA targets for allograft rejection and GvHD therapy.
    Padet L; Loubaki L; Bazin R
    Clin Transplant; 2015 Jun; 29(6):543-6. PubMed ID: 25832981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-class II -DR humanized monoclonal antibody, IMMU-114, blocks allogeneic immune response.
    Park KH; Sawada T; Murakami T; Ishii Y; Yasuo M; Fuchinoue S; Goldenberg DM; Kubota K
    Am J Surg; 2012 Oct; 204(4):527-34. PubMed ID: 22658578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts.
    Jones TR; Ha J; Williams MA; Adams AB; Durham MM; Rees PA; Cowan SR; Pearson TC; Larsen CP
    J Immunol; 2002 Feb; 168(3):1123-30. PubMed ID: 11801646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal anti-TNF-alpha suppresses graft vs host disease reactions in an in vitro human skin model.
    Dickinson AM; Sviland L; Jackson G; Dunn J; Stephens S; Proctor SJ
    Cytokine; 1994 Mar; 6(2):141-6. PubMed ID: 8031996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand.
    Chou AH; Tsai HF; Lin LL; Hsieh SL; Hsu PI; Hsu PN
    J Immunol; 2001 Aug; 167(3):1347-52. PubMed ID: 11466352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis.
    Mizuhara H; Uno M; Seki N; Yamashita M; Yamaoka M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
    Hepatology; 1996 Jun; 23(6):1608-15. PubMed ID: 8675184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of interferon-gamma and tumour necrosis factor-alpha on the development of cytotoxic T lymphocytes in autologous mixed lymphocyte tumour cultures with human melanoma.
    Roth AD; Hornicek FJ; Gerstner CG; Kirkwood JM
    Clin Exp Immunol; 1991 Oct; 86(1):163-72. PubMed ID: 1833098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
    Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
    Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon (IFN)-gamma is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-gamma and tumour necrosis factor-alpha production.
    Konur A; Schulz U; Eissner G; Andreesen R; Holler E
    Br J Dermatol; 2005 Jun; 152(6):1134-42. PubMed ID: 15948973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor.
    Le JM; Vilcek J
    J Immunol; 1987 Nov; 139(10):3330-7. PubMed ID: 3119705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine gene expression in the mixed lymphocyte culture in allogenic bone marrow transplants as a predictive method for transplantation-related complications.
    Tanaka J; Imamura M; Kasai M; Kobayashi S; Hashino S; Kobayashi H; Sakurada K; Miyazaki T
    Br J Haematol; 1994 Jun; 87(2):415-8. PubMed ID: 7947291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T10B9 action: the effect of anti-T-cell antibody mitogenicity and graft rejection on the first dose cytokine response.
    Brown S; Lucas B; Waid T; McKeown W; Tsuchida M; Thompson J
    Transplant Proc; 1997; 29(1-2):315-6. PubMed ID: 9123017
    [No Abstract]   [Full Text] [Related]  

  • 19. LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response.
    Tamada K; Shimozaki K; Chapoval AI; Zhai Y; Su J; Chen SF; Hsieh SL; Nagata S; Ni J; Chen L
    J Immunol; 2000 Apr; 164(8):4105-10. PubMed ID: 10754304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. gamma-Interferon plays a key role in T-cell-induced tumor regression.
    Tuttle TM; McCrady CW; Inge TH; Salour M; Bear HD
    Cancer Res; 1993 Feb; 53(4):833-9. PubMed ID: 8428364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.